-+ 0.00%
-+ 0.00%
-+ 0.00%

*Psyence BioMed Approves 2026 Fincl Strategy, Board Authorizes Shr Buyback on Value Opportunity

Dow Jones·01/12/2026 13:35:00

Please log in to view news